Back to Results
First PageMeta Content
Bacillus Calmette-Guérin / Cystoscopy / Cancer / Lower urinary tract symptoms / Cystectomy / Medicine / Bladder cancer / Aging-associated diseases


Original Article Compliance With Guidelines for Patients With Bladder Cancer Variation in the Delivery of Care Karim Chamie, MD, MSHS1,2; Christopher S. Saigal, MD, MPH1,2,3; Julie Lai, MS3; Jan M. Hanley, MS3;
Add to Reading List

Document Date: 2011-07-11 19:00:26


Open Document

File Size: 161,49 KB

Share Result on Facebook

City

Lusaka / Washington / DC / Pittsburgh / Los Angeles / Santa Monica / /

Company

3RAND Corporation / Strope SA / Health Services Research Group / StataCorp / 4RAND Corporation / /

Country

Zambia / United States / /

Currency

USD / /

/

Event

Reorganization / /

Facility

University Teaching Hospital / University of California at Los Angeles / National Institute / National Cancer Institute / Wiley Online Library / University of California at Los Angeles School / College Station / University of Minnesota / /

/

IndustryTerm

Upper tract imaging surveillance / care for early stage bladder cancer / study protocol / database applications / Cancer Treat / imaging / care for patients with bladder cancer / individual services / insurance coverage / et al imaging studies / frequent imaging / Treatment of Cancer / Cancer Care / Online Library / Treatment of nonmuscle invading bladder cancer / robotic technology / upper tract imaging / radiographic imaging / /

MedicalCondition

Urologic Diseases / pT1 transitional-cell bladder tumours / bladder tumor / transitional-cell carcinoma / stage Ta T1 bladder cancer / T1 tumor / Ta T1 bladder tumors / bladder cancer / academic cancer / Bladder Cancer Care/Chamie / center Academic cancer / low risk superficial bladder cancer / non-invasive bladder tumors / early stage bladder cancer / papillary carcinoma / illness / MS / invasive bladder cancer / comprehensive cancer / undifferentiated tumor / cancers / tumor / Results (SEER) program tumor / chronic condition / cancer / disease / T1 disease / recurrent primary superficial bladder cancer / muscle-invasive bladder cancer / Kidney Diseases / unnecessary disease / tumour / initial bladder cancer / Diabetes / likely developed disease / non-muscle-invasive bladder cancer / nonmuscle invading bladder cancer / bladder tumors / recurrent superficial carcinoma / high-grade disease / muscleinvasive bladder cancer / primary superficial bladder cancer / kidney cancer / superficial bladder cancer / /

MedicalTreatment

radiation therapy / intravesical therapy / chemotherapy / radiotherapy / surgery / immunotherapy / BCG therapy / /

Organization

National Cancer Institute / European Organisation for Research and Treatment / Ruth L. Kirschstein National Research Service / National Institute / Institute of Medicine / BCG OR / American Joint Committee on Cancer / European Organization for Research and Treatment of Cancer Genitourinary Group / Intravesical administration / University of California at Los Angeles School of Public Health / University of Minnesota / Minneapolis / Medicare / American Cancer Society / David Geffen School of Medicine / European Association of Urology / office of Research / American Urological Association / 2Jonsson Comprehensive Cancer Center / University Teaching Hospital / office of Research / Development / and Information / International Criminal Court / University of California at Los Angeles / US Government Printing Office / TNM / /

Person

Claude M. Setodji / Karim Chamie / Badrinath R. Konety / Julie Lai / Ruth L. Kirschstein / Jan M. Hanley / Tumor / Ward E. Cancer / Christopher S. Saigal / Mark S. Litwin / /

Position

Principal Investigator / Physician / Corresponding author / Governor / comorbidity index using physician / treating physician / surgeon / medium-volume surgeon / /

Product

mitomycin / /

ProvinceOrState

Minnesota / Pennsylvania / California / /

RadioStation

Epstein AM / /

Region

Midwest / /

Technology

alpha / study protocol / radiation / AV / chemotherapy / robotic technology / /

URL

http /

SocialTag